ArticlePublic health challenges2026
Impacts of the One Big Beautiful Bill Act on African Public Health Systems.
Article in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The enactment of the One Big Beautiful Bill Act (OBBBA) in July 2025 represents a fundamental shift in United States global health financing, with significant implications for African public health systems. For more than three decades, US development assistance for health particularly through initiatives such as the President's Emergency Plan for AIDS Relief (PEPFAR), the President's Malaria Initiative, and maternal and child health programs-has been central to disease control and health system strengthening across sub-Saharan Africa. OBBBA institutionalizes reduced funding baselines under an "America First Global Health Strategy," constraining bilateral assistance and limiting flexible mechanisms that previously supported surveillance, laboratory systems, workforce development, and pandemic preparedness. This perspective examines the anticipated consequences of OBBBA for African public health through three interconnected lenses: disease-specific impacts on HIV/AIDS, tuberculosis, malaria, and maternal and child health; systemic effects on health systems, including workforce sustainability, supply chains, surveillance, and research infrastructure; and broader economic and geopolitical implications for health sovereignty and partnership dynamics. Drawing on existing empirical evidence, modeling studies, and historical analogues of funding disruptions, we argue that abrupt reductions in US global health financing risk reversing hard-won gains in disease control, exacerbating health system fragility, and increasing vulnerability to emerging infectious threats. At the same time, the policy shift may accelerate diversification of partnerships and prompt renewed debates on domestic resource mobilization and African health sovereignty. We conclude that coordinated responses by African governments, regional bodies, international institutions, and development partners are urgently required to mitigate risks, protect treatment continuity, and sustain progress toward global health security and the Sustainable Development Goals.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.